Lila Bio
Lila Bio develops therapeutic proteins using AI-powered protein design and experimental discovery platforms. Its targeted radiotherapy platform focuses on solid tumors, while its long-acting injectable platform targets non-oncology diseases; the company aims to develop medicines that improve care for people with cancer and other debilitating diseases.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2023
- Employees
- 10
- Members see funding amounts. .
- Founders
- Jake Kraft, PhD, Anindya Roy, PhD, Hua Bai, PhD, Sheila Gujrathi, MD
Is this your organization? Claim it
Members see Lila Bio's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Anindya Roy Executive Officer, Director, CSO & Co-Founder
-
Jake Kraft CEO & Co-Founder
-
Hua Bai Director of Protein Design & Co-Founder